112 related articles for article (PubMed ID: 1917519)
1. Role of serum albumin as a carrier of 99mTc-complex to tumor tissue.
Takeda A; Hibino T; Hoshino A; Okumura H; Okada S
Int J Rad Appl Instrum B; 1991; 18(5):499-502. PubMed ID: 1917519
[TBL] [Abstract][Full Text] [Related]
2. Intensification of tumor affinity of 99mTc-DL-homocysteine by cooperative use of SH-containing compounds.
Takeda A; Hibino T; Okada S
Int J Rad Appl Instrum B; 1989; 16(6):581-5. PubMed ID: 2606713
[TBL] [Abstract][Full Text] [Related]
3. Tumor detection with some 99mTc-labeled S-containing amino acids.
Tamemasa O; Takeda A; Goto R
Gan; 1984 May; 75(5):395-402. PubMed ID: 6745561
[TBL] [Abstract][Full Text] [Related]
4. Tumor accumulation mechanism of 99mTc-DL-homocysteine, a model compound for the development of tumor-imaging radiopharmaceuticals.
Takeda A; Hibino T; Hoshino A; Okada S
Int J Rad Appl Instrum B; 1990; 17(8):751-5. PubMed ID: 2079421
[TBL] [Abstract][Full Text] [Related]
5. Chemical properties of technetium-99m-DL-homocysteine, a possible tumor-imaging agent.
Takeda A; Goto R; Okada S
Ann Nucl Med; 1988 Nov; 2(2):55-8. PubMed ID: 3275108
[TBL] [Abstract][Full Text] [Related]
6. The design of a pentavalent 99mTc-dimercaptosuccinate complex as a tumor imaging agent.
Yokoyama A; Hata N; Horiuchi K; Masuda H; Saji H; Ohta H; Yamamoto K; Endo K; Torizuka K
Int J Nucl Med Biol; 1985; 12(4):273-9. PubMed ID: 3002999
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of 99mTc-labeled modified serum albumin for tumor detection.
Guerdoud LM; Ouellet R; Van Lier JE
Nucl Med Biol; 1994 Nov; 21(8):1101-8. PubMed ID: 9234368
[TBL] [Abstract][Full Text] [Related]
8. 99mTc-DL-Homocysteine, a potential tumor imaging agent.
Tamemasa O; Goto R; Takeda A; Yano M
Radioisotopes; 1984 Sep; 33(9):636-8. PubMed ID: 6515052
[TBL] [Abstract][Full Text] [Related]
9. Chemical form of tumor-tropic 99mTc-DL-homocysteine.
Takeda A; Okada S
Int J Rad Appl Instrum A; 1989; 40(7):565-8. PubMed ID: 2551856
[TBL] [Abstract][Full Text] [Related]
10. [Investigation of 99mTc labeled tumor seeking agents--usefulness of 99mTc-isoniazid].
Yamada N; Takashima H; Nohara F; Fujinawa T; Matsumura T; Koizumi K; Hisada K
Radioisotopes; 1987 Oct; 36(10):505-11. PubMed ID: 3438494
[TBL] [Abstract][Full Text] [Related]
11. [Study on tumor affinity of technetium-99m-labeled radiopharmaceuticals. (1) 99mTc-pertechnetate, 99mTc-human serum albumin, and 99mTc-trasylol].
Ito K; Kobayashi S; Hisada K; Ando A; Tonami N
Radioisotopes; 1976 Oct; 25(10):614-21. PubMed ID: 1088303
[TBL] [Abstract][Full Text] [Related]
12. 99mTc-phytate as a diagnostic probe for assessing inflammatory reaction in malignant tumors.
Fernandes RS; Mota LG; Kalbasi A; Moghbel M; Werner TJ; Alavi A; Rubello D; Cardoso VN; de Barros AL
Nucl Med Commun; 2015 Oct; 36(10):1042-8. PubMed ID: 26147941
[TBL] [Abstract][Full Text] [Related]
13. Pingyangmycin as a 99mTc carrier in tumor localization.
Huang T; Zhang Y; Wang J; Huang J; Liu D; Mong S
Nucl Med Biol; 1995 May; 22(4):537-42. PubMed ID: 7550032
[TBL] [Abstract][Full Text] [Related]
14. Organometallic 99mTc(III) '4 + 1' bombesin(7-14) conjugates: synthesis, radiolabeling, and in vitro/in vivo studies.
Kunstler JU; Veerendra B; Figueroa SD; Sieckman GL; Rold TL; Hoffman TJ; Smith CJ; Pietzsch HJ
Bioconjug Chem; 2007; 18(5):1651-61. PubMed ID: 17663527
[TBL] [Abstract][Full Text] [Related]
15. Radioactive metal complexes with affinity for tumors. II. Biodistribution of radioactivity in cellular and subcellular fractions of tumor tissues.
Karube Y; Iwamoto K; Miura J; Takata J; Matsushima Y
Chem Pharm Bull (Tokyo); 1989 Jul; 37(7):1874-6. PubMed ID: 2509089
[TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo evaluation of a Technetium-99m-labeled cyclic RGD peptide as a specific marker of alpha(V)beta(3) integrin for tumor imaging.
Su ZF; Liu G; Gupta S; Zhu Z; Rusckowski M; Hnatowich DJ
Bioconjug Chem; 2002; 13(3):561-70. PubMed ID: 12009947
[TBL] [Abstract][Full Text] [Related]
17. Bound homocysteine, cysteine, and cysteinylglycine distribution between albumin and globulins.
Hortin GL; Seam N; Hoehn GT
Clin Chem; 2006 Dec; 52(12):2258-64. PubMed ID: 17068168
[TBL] [Abstract][Full Text] [Related]
18. Tumor visualization by 99mTc-labeled ethylenediamine-N,N-diacetic acid.
Karube Y; Maeda T; Ohya M; Kono A; Matsushima Y
Chem Pharm Bull (Tokyo); 1981 Aug; 29(8):2385-7. PubMed ID: 6797744
[No Abstract] [Full Text] [Related]
19. Scintigraphic imaging of the hypoxia marker (99m)technetium-labeled 2,2'-(1,4-diaminobutane)bis(2-methyl-3-butanone) dioxime (99mTc-labeled HL-91; prognox): noninvasive detection of tumor response to the antivascular agent 5,6-dimethylxanthenone-4-acetic acid.
Siim BG; Laux WT; Rutland MD; Palmer BN; Wilson WR
Cancer Res; 2000 Aug; 60(16):4582-8. PubMed ID: 10969810
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of 99mTc-labeled amino acids as radiopharmaceuticals. V. 99mTc complex of ethylenediamine-N,N-diacetic acid as a scintigraphic agent for tumors.
Karube Y; Imoto T; Maeda T; Ohya M; Sugata S; Kono A; Mashiba H; Ichinose Y; Tanaka K; Kaku M
Chem Pharm Bull (Tokyo); 1983 Sep; 31(9):3242-7. PubMed ID: 6421499
[No Abstract] [Full Text] [Related]
[Next] [New Search]
